A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.

Goetsch, Liliane

A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. [electronic resource] - International journal of cancer Jan 2005 - 316-28 p. digital

Publication Type: Journal Article

0020-7136

10.1002/ijc.20543 doi


Animals
Antibodies, Monoclonal--immunology
Antineoplastic Agents, Phytogenic--pharmacology
Breast Neoplasms--pathology
Carcinoma, Hepatocellular--pathology
Carcinoma, Non-Small-Cell Lung--pathology
Cell Cycle--drug effects
Drug Interactions
ErbB Receptors--physiology
Female
Humans
Liver Neoplasms--pathology
Lung Neoplasms--pathology
Mice
Mice, Nude
Receptor, IGF Type 1--immunology
Transplantation, Heterologous
Tumor Cells, Cultured
Vinblastine--analogs & derivatives
Vinorelbine